R01Phase II study of everolimus in combination with...

R01Phase II study of everolimus in combination with octreotide LAR as first line setting for patients with neuroendocrine tumors (I.T.M.O. study): a 5-years update

Bajetta, E., Catena, L., Pusceddu, S., Fazio, N., Blanco, G., Ricci, S., Aieta, M., Pucci, F., Sarno, I., Spada, F., Di Menna, G., Dottorini, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv348.01
Date:
October, 2015
File:
PDF, 32 KB
english, 2015
Conversion to is in progress
Conversion to is failed